Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/18/1995EP0676963A1 Hyaluronic acid-urea pharmaceutical compositions and uses
10/18/1995EP0676962A1 Enhanced pharmaceutical compositions for skin penetration
10/18/1995EP0676961A1 Use of macrolides for the treatment of cerebral ischemia
10/18/1995EP0676960A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
10/18/1995EP0676959A1 Endothelin receptor antagonists
10/18/1995EP0676958A1 Method for inhibiting intracellular viral replication
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676951A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis
10/18/1995EP0676948A1 Antiplaque, antigingivitis, anticaries oral composition
10/18/1995EP0596935B1 Antiviral pharmaceutical compositions for vaginal administration
10/18/1995EP0569393B1 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition
10/18/1995EP0500899B1 Novel 15,16-seco-19-nor progestins
10/18/1995EP0495116B1 Anti-human immunodeficiency virus agent
10/18/1995EP0494297B1 Galenical preparation method for preparing a therapeutical composition particularly based on aspirin
10/18/1995EP0490916B1 Compositions and methods of manufacture of oral dissolvable medicaments
10/18/1995EP0474874B1 Maillard Reaction inhibitor compositions
10/18/1995EP0356435B1 Anti-inflammatory compounds and compositions
10/18/1995CN1110479A Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/18/1995CN1110280A Targeted forms of methyltrithio antitumor agents
10/18/1995CN1110278A Oligonucleotide capable of inhibiting endothelin generation
10/18/1995CN1110172A Compound preparation for curing nutritional iron-deficiency anemia
10/18/1995CN1110162A Peristrophe japonica liniment and preparation method thereof
10/18/1995CN1110160A Nutrient health-care oral liquor containing bee larva nutritive composition
10/18/1995CN1110144A Natural vitamins prevention health-care extract
10/18/1995CN1110143A Oligosaccharid type antipsychotic
10/18/1995CN1110141A Compound Yantongtuoshuang cream
10/18/1995CN1110140A Drug composition for curing dysmnesia and dementia and its preparing method
10/18/1995CN1110139A New usage of Dan phenolic acid A for curing tumour
10/18/1995CN1110138A Traditional Chinese Medicine preparation for curing angiocardiopathy or cerebrovascular disease
10/18/1995CN1110135A Pharmaceutical composition for controlled release
10/18/1995CN1110134A Liposome preparing technology and preparation thereof
10/18/1995CN1110091A Beta-carotene chewing gum and its preparing technology
10/18/1995CN1030081C New 11-aryl sleroid derivs
10/18/1995CN1030077C Process for preparation of antihypercholesterolemic
10/18/1995CN1030075C Process for preparing 3-cycloalkyl-propanamides, their tautomer forms and their salts
10/18/1995CN1030037C Method for preparation of intestine dialysis powder
10/17/1995US5459270 Tachykinin antagonist for central nervous systum disorders and cardiovascular disorders
10/17/1995US5459263 Convert trichlorotrazine to diaminochlorotriazine,then to melarsen acid hydrochloride, reduce to melarsenoxide, react with cysteamine hydrochloride
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459248 Process of preparing etoposide phosphate and etoposide
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/17/1995US5459164 1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylamine compounds are administered to improve glucose tolerance; diabetes
10/17/1995US5459163 Medicament to combat autoimmune diseases
10/17/1995US5459162 Copper citrate in feed
10/17/1995US5459161 Cognition activators
10/17/1995US5459159 Anticarcinogenic/antitumor agents; allowing accumulation in abnormal cells, irradiation with light of specified wavelength
10/17/1995US5459158 Nitric oxide synthase inhibitors; neurodegenerative diseases
10/17/1995US5459157 Pharmaceutical composition for ophthalmic use comprising a nonsteroidal anti-inflammatory and a decongestant drug
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459155 Benzimidazole anthelmintic agents
10/17/1995US5459153 Composition and methods for treatment of acne vulgaris and for retardation of aging
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459151 N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
10/17/1995US5459150 Treatment of allergies and inflammatory diseases
10/17/1995US5459148 Cardiovascular disorders
10/17/1995US5459147 Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma
10/17/1995US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds
10/17/1995US5459141 Compounds 31668P and 31668U, a process for their production and their use
10/17/1995US5459140 Mixture with carbachol; glaucoma
10/17/1995US5459138 Dysfunctions of glutamatergic neurotransmission associated with learning and memory
10/17/1995US5459137 Muscle relaxants, anticonvulsants, neuroprotective agents
10/17/1995US5459136 Skin disorders
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/17/1995US5459134 (Fused) benz (thio) amides
10/17/1995US5459133 Alpha-2 adrenergic agonists, treatment of age related loss of accommodation
10/17/1995US5459127 Cationic lipids for intracellular delivery of biologically active molecules
10/17/1995US5459126 Method for decreasing calcium uptake by cells using selected polycations
10/17/1995US5459057 Treatment with sphignosine or its analog
10/17/1995US5459030 Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
10/17/1995US5458889 Methods and compositions for inhibiting or destroying viruses or retroviruses
10/17/1995US5458886 Free-flowing granular antacid compositions containing titanium dioxide and polysiloxane
10/17/1995US5458883 Method of treating disorders of the eye
10/17/1995CA2082809C Pure crystalline form of rifapentine
10/17/1995CA2060789C Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
10/17/1995CA2048894C Method of treating mast cell disease
10/17/1995CA2030056C 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
10/17/1995CA1337352C Substituted propane-phosphinic acid compounds
10/17/1995CA1337351C Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
10/17/1995CA1337348C Optically active 20,21-dinoreburnamenin derivatives; process for preparing the same; use thereof as drugs and pharmaceutical compositions containing them
10/17/1995CA1337347C Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
10/17/1995CA1337346C Process for preparing 1,5-benzothiazepine derivatives
10/17/1995CA1337344C Benzamino aromatic compounds, preparation process and use in cosmetics
10/17/1995CA1337338C Inositoltriphosphate
10/17/1995CA1337337C Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
10/17/1995CA1337330C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
10/17/1995CA1337328C Odorless aromatic dialdehyde disinfecting and sterilizing composition
10/15/1995WO1995028154A1 Apoptosis inducer
10/15/1995CA2165062A1 Apoptosis inducer
10/15/1995CA2163890A1 Dc-89 derivative
10/13/1995CA2146820A1 Pharmaceutical composition for treating osteoporosis
10/12/1995WO1995027202A1 Screening method using the rzr receptor family
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027054A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995WO1995027044A1 ALPHAVIRUS cDNA VECTORS
10/12/1995WO1995026979A1 Cytotoxic t-cell lymphocyte ('ctl') activity regulation by class i mhc peptides
10/12/1995WO1995026973A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995WO1995026972A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995WO1995026968A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
1 ... 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 ... 7860